Pfizer (PFE) Assets Average (2009 - 2026)

Pfizer (PFE) has 18 years of Assets Average data on file, last reported at $208.1 billion in Q1 2026.

• Assets Average for Q1 2026 came in at $208.1 billion, down 1.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $208.1 billion (down 1.25% YoY), and the FY2025 annual result was $210.8 billion, down 2.61% from the prior year.
• Assets Average was little changed at $208.1 billion in Q1 2026 per PFE's latest filing, from $208.6 billion in the prior quarter.
• Over five years, Assets Average peaked at $223.8 billion in Q1 2024 and troughed at $118.2 billion in Q4 2022.
• A 5-year average of $198.3 billion and a median of $208.1 billion in 2026 frame the typical range for Assets Average.
• The sharpest annual moves came in 2023 and 2025: Assets Average jumped 85.4% in 2023, then slipped 5.85% in 2025.
• A 5-year view of Assets Average shows it stood at $119.1 billion in 2022, then jumped by 85.4% to $220.8 billion in 2023, then retreated by 1.95% to $216.4 billion in 2024, then decreased by 3.63% to $208.6 billion in 2025, then decreased by 0.24% to $208.1 billion in 2026.
• Business Quant data shows PFE's Assets Average at $208.1 billion in Q1 2026, $208.6 billion in Q4 2025, and $207.5 billion in Q3 2025.